Johnson & Johnson: We have a problem
The scent of baby powder is more evocative than that of coconut, chocolate or mothballs, according to Johnson and Johnson’s findings from blind tests. The multibillion dollar behomoth has apparently kept under raps any scientific studies that connect ovarian cancer with its baby powder. Instead, it persists with its marketing of the powder, which is considered “cosmetic,” and thus escapes FDA regulatory approval:
At Johnson’s®, we love babies. And we understand how to soothe and relieve baby soft skin. That’s why Johnson’s baby powder is designed to gently absorb excess moisture helping skin feel comfortable. Our incredibly soft, hypoallergenic, dermatologist and allergy-tested formula glides over skin to leave it feeling delicately soft and dry while providing soothing relief…
In the meantime, in the past several months we have seen some large verdicts against Johnson & Johnson for ovarian cancer cases. Just today, the NY Times Well blog discusses recent baby powder-ovarian cancer cases against Johnson & Johnson. Our firm is actively representing a client who has been an ovarian cancer patient for a few years, and who only realized that her decades’ long ritual of using Shower-to-Shower is linked to ovarian cancer. If you or someone you care about has ovarian cancer and has also had the routine of using talc powder, I would like to speak with you about your possible case. Email me at Catherine@Stritmatter.com or call me at 206.448.1777.
Johnson & Johnson: We have a problem. And you need to inform the public about it, rather than sweeping it under the rug.